Protecting patient privacy by quantifiable control of disclosures in disseminated databases

International Journal of Medical Informatics
L Ohno-MachadoS A Vinterbo

Abstract

One of the fundamental rights of patients is to have their privacy protected by health care organizations, so that information that can be used to identify a particular individual is not used to reveal sensitive patient data such as diagnoses, reasons for ordering tests, test results, etc. A common practice is to remove sensitive data from databases that are disseminated to the public, but this can make the disseminated database useless for important public health purposes. If the degree of anonymity of a disseminated data set could be measured, it would be possible to design algorithms that can assure that the desired level of confidentiality is achieved. Privacy protection in disseminated databases can be facilitated by the use of special ambiguation algorithms. Most of these algorithms are aimed at making one individual indistinguishable from one or more of his peers. However, even in databases considered "anonymous", it may still be possible to obtain sensitive information about some individuals or groups of individuals with the use of pattern recognition algorithms. In this article, we study the problem of determining the degree of ambiguation in disseminated databases and discuss its implications in the development and te...Continue Reading

References

Sep 2, 1998·International Journal of Medical Informatics·B Barber
Apr 17, 1999·Artificial Intelligence in Medicine·A Ohrn, L Ohno-Machado
Apr 21, 1999·Statistics in Medicine·M P ArmstrongD L Zimmerman
Jan 13, 2001·International Journal of Medical Informatics·C Safran, H Goldberg
Jan 13, 2001·International Journal of Medical Informatics·J G Anderson
May 8, 2001·International Journal of Medical Informatics·B Sadan
Jan 18, 2002·The New England Journal of Medicine·Jennifer Kulynych, David Korn
Oct 11, 2002·The New England Journal of Medicine·Jennifer Kulynych, David Korn
Apr 11, 2003·The New England Journal of Medicine·George J Annas
Aug 12, 2003·International Journal of Medical Informatics·Yu-Cheng ChiangDa-Wei Wang
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·E B Andrews, UNKNOWN International Society for Pharmacoepidemiology

❮ Previous
Next ❯

Citations

Dec 28, 2006·Journal of Digital Imaging·Rita NoumeirJean-Marc Lina
May 11, 2007·Journal of Medical Systems·Willy Susilo, Khin Than Win
Jun 2, 2009·Journal of Medical Systems·Alejandro Enrique Flores ZunigaWilly Susilo
Dec 13, 2006·International Journal of Health Geographics·John S BrownsteinKenneth D Mandl
Jan 25, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Maarten J ten BergWouter W van Solinge
Dec 17, 2005·Journal of the American Medical Informatics Association : JAMIA·Christopher A CassaKenneth D Mandl
Nov 15, 2011·Journal of the American Medical Informatics Association : JAMIA·Lucila Ohno-MachadoUNKNOWN iDASH team
Dec 21, 2010·Journal of the American Medical Informatics Association : JAMIA·Bradley MalinDaniel Masys
Oct 13, 2012·Journal of the American Medical Informatics Association : JAMIA·James GardnerLucila Ohno-Machado
Apr 12, 2012·Journal of the American Medical Informatics Association : JAMIA·Xiaoqian JiangLucila Ohno-Machado
Jan 27, 2009·International Journal of Medical Informatics·Wen-Yuan Jen
Jun 5, 2007·Artificial Intelligence in Medicine·Bradley Malin
Jul 13, 2004·International Journal of Medical Informatics·Heimar F Marin
Dec 12, 2012·Journal of Biomedical Informatics·Sergio MartínezAida Valls
Oct 25, 2016·Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes·Marc DilauroNajla Fasih
Feb 27, 2010·Nursing Ethics·Nahid Dehghan Nayeri, Mohammad Aghajani
Apr 28, 2005·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Shahram Kashani, Mohammad Muhtaseb
Sep 9, 2006·Vox Sanguinis·Richard J Davey
Feb 2, 2008·The HIM Journal·Khin Than Win
Nov 1, 2012·Personalized Medicine·Bradford R Hirsch, Amy P Abernethy
Dec 16, 2020·Nursing Open·Neriman AkanselAysel Özdemir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.